Paper29326164
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y and 10 others. J Biol Chem, 2018. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). Papers, record 29326164. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29326164
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Amino Acid Transport System ASC | Major topic |
| Colonic Neoplasms | Major topic |
| Large Neutral Amino Acid-Transporter 1 | Major topic |
| Lung Neoplasms | Major topic |
| Minor Histocompatibility Antigens | Major topic |
| Neoplasm Proteins | Major topic |
| Absorption, Physiological | |
| Animals | |
| Antineoplastic Agents | |
| CRISPR-Cas Systems | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Clone Cells | |
| Female | |
| Gene Deletion | |
| Gene Knockout Techniques | |
| Glutamine | |
| Humans | |
| Mechanistic Target of Rapamycin Complex 1 | |
| Membrane Transport Modulators | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Recombinant Proteins |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23103253 | HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. | Mol Cell | 2012 | https://conductscience.org/library/papers/23103253 | PubMed |
| 2 | 18992769 | Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. | Pharmacol Ther | 2009 | https://conductscience.org/library/papers/18992769 | PubMed |
| 3 | 9603962 | Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9603962 | PubMed |
| 4 | 25693838 | Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development. | J Pathol | 2015 | https://conductscience.org/library/papers/25693838 | PubMed |
| 5 | 27129276 | Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27129276 | PubMed |
| 6 | 27988359 | Targeting amino acid metabolism for cancer therapy. | Drug Discov Today | 2017 | https://conductscience.org/library/papers/27988359 | PubMed |
| 7 | 23402769 | Nutrient transporters: the Achilles' heel of anabolism. | Trends Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23402769 | PubMed |
| 8 | 19033189 | Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/19033189 | PubMed |
| 9 | 22749528 | Glutaminolysis activates Rag-mTORC1 signaling. | Mol Cell | 2012 | https://conductscience.org/library/papers/22749528 | PubMed |
| 10 | 18253116 | Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18253116 | PubMed |
| 11 | 17645414 | Controlling cell growth and survival through regulated nutrient transporter expression. | Biochem J | 2007 | https://conductscience.org/library/papers/17645414 | PubMed |
| 12 | 26455325 | ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. | Oncogene | 2016 | https://conductscience.org/library/papers/26455325 | PubMed |
| 13 | 10698697 | Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance. | Biochem J | 2000 | https://conductscience.org/library/papers/10698697 | PubMed |
| 14 | 26658722 | Multiple amino acid sensing inputs to mTORC1. | Cell Res | 2016 | https://conductscience.org/library/papers/26658722 | PubMed |
| 15 | 25482130 | L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia. | Leukemia | 2015 | https://conductscience.org/library/papers/25482130 | PubMed |
| 16 | 27302165 | Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth. | Cancer Res | 2016 | https://conductscience.org/library/papers/27302165 | PubMed |
| 17 | 28074546 | Hypoxia and cellular metabolism in tumour pathophysiology. | J Physiol | 2017 | https://conductscience.org/library/papers/28074546 | PubMed |
| 18 | 19900191 | L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. | Cancer Sci | 2010 | https://conductscience.org/library/papers/19900191 | PubMed |
| 19 | 25337245 | Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/25337245 | PubMed |
| 20 | 24014241 | Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. | Blood | 2013 | https://conductscience.org/library/papers/24014241 | PubMed |
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941900 | Mitochondrial Metabolic Reprogramming and Immune Evasion in Colorectal Cancer: Research Advances and Mechanistic Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941900 | PubMed |
| 42835604 | Integrative proteomic and metabolomic analysis reveals that ouabain inhibits DLBCL proliferation by reprogramming arginine-driven metabolic networks. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42835604 | PubMed |
| 42602393 | Amino acid metabolic regulatory network in tumor immune escape: mechanistic exploration and intervention directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42602393 | PubMed |
| 42450745 | Optimal Combination of Glycine, Asparagine, and Phenylalanine Promotes α-Casein Synthesis and Secretion in MAC-T Cells Through Activation of the PI3K-AKT-mTOR Pathway. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42450745 | PubMed |
| 42005455 | Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis. | J Oral Biol Craniofac Res | 2026 | https://conductscience.org/library/papers/42005455 | PubMed |
| 41969460 | Prognostic stratification in non-small cell lung cancer using a TIDE-informed transcriptomic signature: model development and validation. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41969460 | PubMed |
| 41790324 | Exploring metabolic signatures in urine using NMR for improved prognosis of gliomas. | Metabolomics | 2026 | https://conductscience.org/library/papers/41790324 | PubMed |
| 41693758 | Fueling the Fire: How Glutamine Metabolism Sustains Leukemia Growth and Resistance. | BioMed (Basel) | 2026 | https://conductscience.org/library/papers/41693758 | PubMed |
| 41614938 | Comprehensive Transcriptomic Analysis and Biomarker Prioritization of Hydroxyprogesterone in Breast Cancer. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41614938 | PubMed |
| 41602107 | Tryptophan metabolism at the crossroads of the neuro-immuno-microbial axis: implications for precision medicine in chronic diseases. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41602107 | PubMed |
| 41463320 | Integrative Single-Cell and Machine Learning Analysis Develops a Glutamine Metabolism-Based Prognostic Model and Identifies MSMO1 as a Therapeutic Target in Osteosarcoma. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463320 | PubMed |
| 41463097 | Asparagine synthetase (ASNS) Drives Tumorigenicity in Small Cell Lung Cancer. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463097 | PubMed |
| 41226775 | Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226775 | PubMed |
| 41116060 | TXNIP mediates LAT1/SLC7A5 endocytosis to limit amino acid uptake in cells entering quiescence. | EMBO J | 2025 | https://conductscience.org/library/papers/41116060 | PubMed |
| 41003134 | Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications. | J Pers Med | 2025 | https://conductscience.org/library/papers/41003134 | PubMed |
| 40951358 | Crosstalk between dysregulated amino acid sensing and glucose and lipid metabolism in colorectal cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/40951358 | PubMed |
| 40948541 | Optimization of CAR-T therapy based on metabolic remodeling of the tumor immune microenvironment in diffuse large B-cell lymphoma. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/40948541 | PubMed |
| 40837928 | Expression of Alanine-Serine-Cysteine Transporter 2 (ASCT2) and L-type Amino Acid Transporter 1 (LAT1) in Low-Grade and High-Grade Gliomas: An Analysis of Open-Access Immunohistochemical Data. | Cureus | 2025 | https://conductscience.org/library/papers/40837928 | PubMed |
| 40819934 | Recent advances in ASCT2 inhibitors: ligand design and therapeutic applications. | Future Med Chem | 2025 | https://conductscience.org/library/papers/40819934 | PubMed |
| 40469185 | Metabolic reprogramming and therapeutic targeting in non-small cell lung cancer: emerging insights beyond the Warburg effect. | Front Oncol | 2025 | https://conductscience.org/library/papers/40469185 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29326164
GET https://conductscience.org/api/papers/v1/29326164/references?page=2